Benzofuran-Based Estrogen Receptor α Modulators as Anti-Cancer Therapeutics: In Silico and Experimental Studies
作者:Min Leow、Hui Li Chin、Peggy Yu、Kalyan Pasunooti、Raymond Xu Tay、Dawei Zhang、Ho Yoon、Xue-Wei Liu
DOI:10.2174/0929867311320220007
日期:2013.6.1
In the search for new estrogen receptor alpha (ERα) modulators, a trial molecular screening was conducted and
5,6-dihydroxybenzofuran was identified as a possible drug target for ERα. The target molecular modelling molecule 1 and
a series of 5,6-dihydroxybenzofurans have been synthesized and evaluated for their anti-proliferation activities against
MCF-7 and MDA-MB-231 cells. From the SAR studies, potential functional groups have been identified, the two hydroxyl
groups at C-5 and C-6 and the phenyl ring at C-2, which showed considerable cytotoxicity in MCF-7 breast cancer
cells. In addition, the apoptotic abilities of the compounds have been measured in both MCF-7 ER(+) and MDA-MB-231
ER(-) breast cancer cells. The results demonstrated that our compounds inhibit MCF-7 breast cancer cells via ER(+).
These preliminary results provide valuable information towards the identification of important functional groups present
on 5,6-dihydroxybenzofuran, which could be a promising scaffold for designing novel ER ligands.
在寻找新的雌激素受体α(ERα)调节剂的过程中,进行了一次分子筛选试验,并确定5,6-二羟基苯并呋喃作为可能的ERα药物作用靶点。针对该目标分子模型,合成了一系列5,6-二羟基苯并呋喃分子,并评估了它们对MCF-7和MDA-MB-231细胞的抗增殖活性。通过结构-活性关系(SAR)研究,鉴定出潜在功能团,即C-5和C-6位置上的两个羟基以及C-2位置的苯环,这些功能团在MCF-7乳腺癌细胞中显示出显著的细胞毒性。此外,该系列化合物在MCF-7 ER(+)和MDA-MB-231 ER(-)乳腺癌细胞中的凋亡能力也得到了测定。结果表明,我们的化合物通过ER(+)途径抑制了MCF-7乳腺癌细胞。这些初步结果为鉴定5,6-二羟基苯并呋喃上的重要功能团提供了宝贵信息,该分子骨架可能成为设计新型ER配体的有前景的支架。